HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Rose Sheet

Executive Summary

Parlux Fragrances: Second quarter sales for the period ended Sept. 30, 2006 were flat, decreasing 1% to $39.1 mil., while net income dropped 20% to $3.5 mil. due to lower gross margins, royalties on non-fragrance products and additional expenses, company announces Jan. 9 after a delay in its financial review. Net sales for the first two quarters increased 9% to $79.8 mil., Parlux says. Third quarter sales (ended Dec. 31) were higher than the prior-year period, and the $63 mil. in cash received from sale of the Perry Ellis fragrance license "leaves Parlux well-positioned to enhance value for our shareholders," according to CEO Ilia Lekach. Parlux, which markets the Paris Hilton,GUESS? and Ocean Pacific brands, among others, sold Perry Ellis back to licensor Perry Ellis International in December (1"The Rose Sheet" Dec. 11, 2006, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS014470

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel